It was shown that BC has anti-inflammatory effects reducing the IL-1β and COX-2 expression through inhibition of NF-κB signaling pathway in human colon cancer cell line HT-29 [40]. The gene discussed is NFKB1; the disease is malignant colon neoplasm.